About us
Our promise is to ensure that women live longer and fuller lives as they deserve through earlier detection of breast cancer.
Our Mission
We help doctors detect breast cancer earlier to improve survival and quality of life.
Our mission is to harness the power of Artificial Intelligence to ensure that the faster and earlier detection of breast cancers can help to save more women’s lives.
Our aim is also to use AI to help radiologists identify breast cancers as early as possible so that earlier treatment will increase the likelihood of success and reduce unnecessary recalls.
Transpara Breast Care is the brainchild of two of the world’s most renowned experts in the field who brought their knowledge of cutting-edge medicine, physics and artificial intelligence to optimize the early diagnosis of breast cancer.
Professor Sir Michael Brady of MIT and Oxford University in England and Professor Nico Karssemeijer of Radboud University in The Netherlands founded ScreenPoint Medical, developers of Transpara.
